RCINJ Lymphoma Tumor Board - 6/23/2025

Add to Calendar RCINJ Lymphoma Tumor Board - 6/23/2025 6/23/2025 12:00:00 PM 6/23/2025 1:00:00 PM America/New_York For More Details: https://rutgers.cloud-cme.com/course/courseoverview?EID=23643 Description: Provided by Rutgers Cancer Institute of New Jersey Objective(s): 1 Analyze oncological decision making processes and judgment to identify approaches to patient management and care 2 Evaluate oncology research developments that will continually improve the quality of care for cancer patients 3 Monitor and continually improve the quality of care to patients with cancer 4 Relate case findings to health... Rutgers CINJ, 200 Little Albany Street, East Tower - 9th Floor, Room 916 false MM/DD/YYYY


Date & Location
Monday, June 23, 2025, 12:00 PM - 1:00 PM, Rutgers CINJ, 200 Little Albany Street, East Tower - 9th Floor, Room 916, New Brunswick, NJ

Overview
Provided by Rutgers Cancer Institute of New Jersey

Objective(s): 1 Analyze oncological decision making processes and judgment to identify approaches to patient management and care 2 Evaluate oncology research developments that will continually improve the quality of care for cancer patients 3 Monitor and continually improve the quality of care to patients with cancer 4 Relate case findings to healthcare team members in order to improve the multidisciplinary approach in the management of patients with cancer
Location: Rutgers CINJ, 200 Little Albany Street, East Tower - 9th Floor, Room 916

Faculty Disclosures:
Matthew Matasar, MD (Consultant-Genentech|Consultant-Roche|Consultant-Regeneron Pharmaceuticals|Consultant-AstraZeneca|Consultant-ADC Therapeutics|Consultant-BMS|Consultant-Genmab|Consultant-Johnson & Johnson|Other: Expert Witness-Bayer|Consultant-Arvinas|Consultant-allogene - 05/21/2025)
Joanna Rhodes, MD (Consultant-AbbVie|Consultant-AstraZeneca|Consultant-Bristol Myers Squibb|Consultant-Beigene|Consultant-Genentech|Consultant-Genmab|Consultant-Janssen Pharmaceuticals|Grant/research support-Janssen Pharmaceuticals|Grant/research support-Lilly (Relationship has ended)|Consultant-Lilly|Grant/research support-AbbVie (Relationship has ended)|Consultant-ADC Therapeutics|Consultant-LOXO Oncology |Consultant-Pharmacyclics|Consultant-Seagen (Relationship has ended)|Independent Contractor (including contracted research)-Curio Science|Independent Contractor (including contracted research)-Aptitude Health|Independent Contractor (including contracted research)-MJH Life Sciences|Consultant-Incyte|Consultant-Merck|Grant/research support-Merck - 06/04/2025)
Yun Kyoung (Claire) Tiger, MD, PhD (Nothing to disclose - 04/23/2025)
Download Handout

Target Audience
Professions - Medical Fellow, Medical Resident, Nurse Practitioner, Pharmacist, Physician, Physician Assistant, Registered Nurse, Student

Objectives
 
Upon completion of this activity, participants should be better able to:

 


  1. Analyze oncological decision making processes and judgment to identify approaches to patient management and care
  2. Evaluate oncology research developments that will continually improve the quality of care for cancer patients
  3. Monitor and continually improve the quality of care to patients with cancer
  4. Relate case findings to healthcare team members in order to improve the multidisciplinary approach in the management of patients with cancer

Accreditation and Credit Designation

In support of improving patient care, Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

 

Rutgers Biomedical and Health Sciences designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity is awarded 1 ANCC contact hour.

This knowledge-based activity qualifies for 1 contact hour of continuing pharmacy education credit.


Additional Information
Contact: Lauren Farer - [email protected]; Shanae Williams - [email protected]; Jennifer Guerro - [email protected]

Credits
AMA PRA Category 1 Credits™ (1.00 hours), ACPE Credits (1.00 hours), ANCC Contact Hours (1.00 hours), Non-Physician Attendance (1.00 hours)